---
title: "Metis TechBio Denies CSRC Supplemental Information Request Report and Warns Against Market Rumours"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287587157.md"
description: "Metis TechBio Co., Ltd. has issued a clarification denying media reports that it received supplemental information requests from the China Securities Regulatory Commission. The company stated these claims are inaccurate and warned against relying on market rumors. Metis TechBio emphasized it has not received any such requests since its H share listing approval and may pursue legal action for reputational damage. It urged shareholders to base decisions on official announcements and will provide further disclosures as required."
datetime: "2026-05-26T04:37:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287587157.md)
  - [en](https://longbridge.com/en/news/287587157.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287587157.md)
---

# Metis TechBio Denies CSRC Supplemental Information Request Report and Warns Against Market Rumours

### Meet Samuel – Your Personal Investing Prophet

-   Start a conversation with TipRanks’ trusted, data-backed investment intelligence
-   Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds

Metis TechBio Co., Ltd. Class H ( (HK:7666) ) has shared an announcement.

Metis TechBio Co., Ltd. issued a voluntary clarification after media reports claimed it was among 38 companies that received supplemental information requests from the China Securities Regulatory Commission regarding their listings. The company stated that this information is factually inaccurate and misleading, noting it has not received any such requests since obtaining CSRC filing approval for its H share listing and full circulation in March 2026 and successfully listing in Hong Kong in May 2026.

In response to what it calls false media information and potential reputational damage, Metis TechBio said it reserves the right to pursue legal action to protect its legitimate rights and interests. The company urged shareholders and potential investors not to rely on market rumours, to base decisions only on its official announcements, and to exercise caution when dealing in its securities, adding it will provide further disclosures as required by Hong Kong listing and securities laws.

**More about Metis TechBio Co., Ltd. Class H**

Metis TechBio Co., Ltd. is a joint stock company incorporated in the People’s Republic of China and listed on the Main Board of the Hong Kong Stock Exchange under stock code 7666. The company has issued H shares in Hong Kong and is subject to oversight by the China Securities Regulatory Commission and Hong Kong market regulations, targeting investors in the Hong Kong and mainland China capital markets.

**Average Trading Volume:** 19,544,819

### Related Stocks

- [07666.HK](https://longbridge.com/en/quote/07666.HK.md)

## Related News & Research

- [Why This Invesco ETF Might Be the Most Underrated Index Fund Available Today](https://longbridge.com/en/news/287544443.md)
- [Gel-based cooling wear trialled in Singapore can potentially reduce body heat by 9 deg C](https://longbridge.com/en/news/287440668.md)
- [Blaze Minerals Seeks ASX Quotation for 50 Million New Shares](https://longbridge.com/en/news/287602251.md)
- [Explainer - China's latest coal mine closures, in context](https://longbridge.com/en/news/287572855.md)
- [Driving the future of Northern Ireland’s manufacturing powerhouses](https://longbridge.com/en/news/287579890.md)